Supplements

5-Amino-1-MQ

50 mg per capsule

5-Amino-1-MQ is a finished dietary supplement delivering 5-amino-1-methylquinolinium — a small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor — in oral capsule form: 50 mg per capsule, 60 capsules per bottle.

Quantity

$71.99$89.9920% Off

Technical notes

Material Profile

Supplement Facts per 1 capsule: 5-Amino-1-MQ 50 mg. Servings per container: 60. Daily value not established.

5-Amino-1-methylquinolinium has been studied in the literature as a selective inhibitor of NNMT, an enzyme involved in nicotinamide methylation and cellular NAD+ salvage. Preclinical research has explored NNMT inhibition in models of metabolic regulation, adipose-tissue signaling, and cellular energy balance.

Suggested use: take 1 capsule daily with water or as recommended by a healthcare professional. Do not exceed the recommended dose. Consult a physician before use if pregnant, nursing, under 18, taking medication, or managing a medical condition.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Literature

Research Citations

Curated entry points into the peer-reviewed record for this compound. Links open indexed searches at the U.S. National Library of Medicine so you can verify the current literature yourself rather than relying on a static citation list.

Compliance

5-Amino-1-MQ is supplied strictly as a laboratory reference material. It is not a drug, supplement, food, or cosmetic, and it is not for therapeutic or diagnostic use, human consumption, or veterinary use. Purchasers are responsible for handling the material in accordance with their institutional and jurisdictional requirements.

← Back to catalog

Customer reviews

Verified Feedback

Rating summary

Loading reviews…

Write a review

Your rating

All reviews are moderated before publication. Reviews describing human or veterinary use cannot be published.

    Shipping & Returns

    Delivery & Refund Policy

    Related Peptides

    Similar by category, dosage, or research focus.